share_log

Have UnitedHealth Group Insiders Been Selling Stock?

Have UnitedHealth Group Insiders Been Selling Stock?

联合健康集团内部人士是否在抛售股票?
Simply Wall St ·  07/21 08:19

We wouldn't blame UnitedHealth Group Incorporated (NYSE:UNH) shareholders if they were a little worried about the fact that Thomas Roos, the Senior VP & Chief Accounting Officer recently netted about US$1.6m selling shares at an average price of US$570. However, that sale only accounted for 8.9% of their holding, so arguably it doesn't say much about their conviction.

如果联合健康集团股份有限公司(纽交所:UNH)的高级副总裁兼首席会计师托马斯·鲁斯最近以平均价值为570美元的价格出售了大约160万美元的股票,股东们可能会感到有点担心。然而,那个交易仅占其持股的8.9%,因此可以认为这并不表示他们的信念。

UnitedHealth Group Insider Transactions Over The Last Year

联合健康集团过去一年里的内部交易

In the last twelve months, the biggest single sale by an insider was when the Chief Executive Officer of UnitedHealthcare, Brian Thompson, sold US$12m worth of shares at a price of US$521 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$565. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 48% of Brian Thompson's holding.

在过去的十二个月中,有关内部交易方面最大的单笔交易是联合健康保健的首席执行官布赖恩·汤普森以每股521美元的价格出售了价值1200万美元的股票。因此,很明显有内部人士想从中获得一些现金,甚至低于当前的565美元的价格。当内部人士以低于当前价格的价格出售时,这表明他们认为较低的价格是公正的。这让我们想知道他们对(更高的)近期估值的看法如何。请注意,卖方出售可能有各种原因,因此我们不确定他们对股票价格的看法。我们注意到最大的单笔交易仅占布赖恩·汤普森持股的48%。

Insiders in UnitedHealth Group didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

联合健康集团内部人士在过去一年里没有买入任何股票。以下是过去12个月内部交易(按公司和个人分类)的图形可视化。点击下面的图表,您可以查看每笔内部交易的详细信息!

big
NYSE:UNH Insider Trading Volume July 21st 2024
纽交所:UNH内部交易成交量于2024年7月21日

I will like UnitedHealth Group better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

如果有大量内部人员买入联合健康集团的股票,我会更喜欢它。在等待时,请查看这个免费的低估值和小盘股票列表,其中有相当多的最近内部购买。

Does UnitedHealth Group Boast High Insider Ownership?

联合健康集团是否拥有较高的内部所有权?

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. UnitedHealth Group insiders own about US$908m worth of shares (which is 0.2% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

对于普通股东而言,了解公司内部人员持有多少股很值得。通常,内部人员持股比例越高,内部人员就越有可能受到激励为长期建设公司。联合健康集团内部人员持有约9,0800万美元的股份(占公司的0.2%)。这种内部人员的重要持股总数通常增加了公司为所有股东谋利益的机会。

So What Do The UnitedHealth Group Insider Transactions Indicate?

联合健康集团内部交易是否表明了什么?

Insiders haven't bought UnitedHealth Group stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, UnitedHealth Group has 5 warning signs (and 1 which can't be ignored) we think you should know about.

内部人员在过去三个月内没有购买联合健康集团的股票,但部分卖出。回顾过去12个月,我们的数据没有显示任何内部购买。虽然内部人员确实在公司中拥有很多股份(这很好),但我们对其交易的分析并没有给我们带来对公司的信心。尽管了解内部人员的持股和交易情况很重要,但在做出任何投资决策之前,我们也要考虑股票面临的风险。例如,联合健康集团有5个警示信号(1个不能忽略的),我们认为您应该了解。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果您想查看另一家公司的信息-一家潜在具有优秀财务状况的公司-请不要错过这个带有高股权回报率和低债务的有趣公司免费列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发